Regeneron Pharmaceuticals (NASDAQ: REGN) last traded at $751.50, down 1.48% on the session. The quote above updates while this page is open; the figures below are drawn from Regeneron Pharmaceuticals’s own filings and are restated only when a new one is published.
Regeneron Pharmaceuticals trades on NASDAQ under the ticker REGN. It is classified in the Healthcare sector, Biotech industry. Its market capitalisation is $79.66 billion.
Healthcare sectorBiotechListed on NASDAQ
Valuation measures for Regeneron Pharmaceuticals, derived from the latest quote and its most recent SEC filing.
| Market cap | $79.66B |
|---|---|
| Enterprise value | $87.22B |
| P/E ratio | 18.61 |
| Price / sales | 5.13 |
| Price / book | 2.51 |
|---|
| Beta | 0.51 |
|---|
Trailing-twelve-month figures tagged in Regeneron Pharmaceuticals's XBRL filings with the SEC.
| Revenue (TTM) | $15.53B |
|---|---|
| Net income (TTM) | $4.33B |
| EPS (TTM) | $40.38 |
| Operating margin | 24.74% |
| Return on equity | 13.65% |
| Cash | $2.46B |
Range and volume for REGN over the past 52 weeks.
| 52-week high | $859.34 |
|---|---|
| 52-week low | $553.87 |
| Volume | 209.7K |
| Average volume | 725.4K |
| Previous close | $762.81 |
Dividend history for Regeneron Pharmaceuticals over the trailing twelve months.
| Dividend yield | 0.48% |
|---|---|
| Dividend per share (TTM) | $3.64 |
| Payout ratio | 9.01% |
Other Healthcare companies tracked on FurlPay Markets.
Invest a chosen dollar amount in Regeneron Pharmaceuticals with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell REGN.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.